Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Wesche

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Toxicological Sciences : an Official Journal of the Society of Toxicology|April 28, 2012
Mode of action associated with development of hemangiosarcoma in mice given pregabalin and assessment of human relevanceKay A Criswell, Jon C Cook, Zbigniew Wojcinski, et al.
Clinical Pharmacology and Therapeutics|July 21, 2020
Pharmacokinetics and Pharmacological Properties of Chloroquine and Hydroxychloroquine in the Context of COVID-19 InfectionMelanie R Nicol, Abhay Joshi, Matthew L Rizk, et al.
Plos Neglected Tropical Diseases|August 5, 2024
The use of quantitative clinical pharmacology approaches to support moxidectin dosing recommendations in lactationNolan D Wood, Danelle Smith, Sally A Kinrade, et al.
Trials|June 5, 2020
Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trialRuanne V Barnabas, Elizabeth Brown, Anna Bershteyn, et al.
British Journal of Clinical Pharmacology|February 3, 2021
Model-informed drug repurposing: A pharmacometric approach to novel pathogen preparedness, response and retrospectionMichael Dodds, Yuan Xiong, Samer Mouksassi, et al.
The American Journal of Tropical Medicine and Hygiene|August 24, 2020
Accelerating Clinical Evaluation of Repurposed Combination Therapies for COVID-19Craig R Rayner, Louis Dron, Jay J H Park, et al.
Malaria Journal|May 10, 2011
Population pharmacokinetics of artesunate and dihydroartemisinin in pregnant and non-pregnant women with malariaCarrie A Morris, Marie A Onyamboko, Edmund Capparelli, et al.
Malaria Journal|March 1, 2011
Pharmacokinetics and pharmacodynamics of artesunate and dihydroartemisinin following oral treatment in pregnant women with asymptomatic Plasmodium falciparum infections in Kinshasa DRCMarie A Onyamboko, Steven R Meshnick, Lawrence Fleckenstein, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 16, 2023
Characterizing the Blood-Stage Antimalarial Activity of Tafenoquine in Healthy Volunteers Experimentally Infected With Plasmodium falciparumBridget E Barber, Azrin N Abd-Rahman, Rebecca Webster, et al.
Clinical Pharmacology and Therapeutics|February 8, 2021
Model-Informed Drug Development for Anti-Infectives: State of the Art and FutureCraig R Rayner, Patrick F Smith, David Andes, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Toxicological Sciences : an Official Journal of the Society of Toxicology|April 28, 2012
Mode of action associated with development of hemangiosarcoma in mice given pregabalin and assessment of human relevanceKay A Criswell, Jon C Cook, Zbigniew Wojcinski, et al.
Clinical Pharmacology and Therapeutics|July 21, 2020
Pharmacokinetics and Pharmacological Properties of Chloroquine and Hydroxychloroquine in the Context of COVID-19 InfectionMelanie R Nicol, Abhay Joshi, Matthew L Rizk, et al.
Plos Neglected Tropical Diseases|August 5, 2024
The use of quantitative clinical pharmacology approaches to support moxidectin dosing recommendations in lactationNolan D Wood, Danelle Smith, Sally A Kinrade, et al.
Trials|June 5, 2020
Efficacy of hydroxychloroquine for post-exposure prophylaxis to prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection among adults exposed to coronavirus disease (COVID-19): a structured summary of a study protocol for a randomised controlled trialRuanne V Barnabas, Elizabeth Brown, Anna Bershteyn, et al.
British Journal of Clinical Pharmacology|February 3, 2021
Model-informed drug repurposing: A pharmacometric approach to novel pathogen preparedness, response and retrospectionMichael Dodds, Yuan Xiong, Samer Mouksassi, et al.
The American Journal of Tropical Medicine and Hygiene|August 24, 2020
Accelerating Clinical Evaluation of Repurposed Combination Therapies for COVID-19Craig R Rayner, Louis Dron, Jay J H Park, et al.
Malaria Journal|May 10, 2011
Population pharmacokinetics of artesunate and dihydroartemisinin in pregnant and non-pregnant women with malariaCarrie A Morris, Marie A Onyamboko, Edmund Capparelli, et al.
Malaria Journal|March 1, 2011
Pharmacokinetics and pharmacodynamics of artesunate and dihydroartemisinin following oral treatment in pregnant women with asymptomatic Plasmodium falciparum infections in Kinshasa DRCMarie A Onyamboko, Steven R Meshnick, Lawrence Fleckenstein, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 16, 2023
Characterizing the Blood-Stage Antimalarial Activity of Tafenoquine in Healthy Volunteers Experimentally Infected With Plasmodium falciparumBridget E Barber, Azrin N Abd-Rahman, Rebecca Webster, et al.
Clinical Pharmacology and Therapeutics|February 8, 2021
Model-Informed Drug Development for Anti-Infectives: State of the Art and FutureCraig R Rayner, Patrick F Smith, David Andes, et al.
Pageof 3